Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 393

1.

Does pycnogenol intensify the efficacy of acetylsalicylic acid in the inhibition of platelet function? In vitro experience.

Golański J, Muchova J, Golański R, Durackova Z, Markuszewski L, Watała C.

Postepy Hig Med Dosw (Online). 2006;60:316-21. Review.

2.

Magnesium inhibits platelet activity--an in vitro study.

Ravn HB, Vissinger H, Kristensen SD, Husted SE.

Thromb Haemost. 1996 Jul;76(1):88-93.

PMID:
8819258
3.

Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity.

Hernandez MR, Tonda R, Pedreño J, Salas E, Arderiu G, Pino M, Serradell M, Escolar G.

J Cardiovasc Med (Hagerstown). 2006 Dec;7(12):859-65.

PMID:
17122671
4.
5.

An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.

Velik-Salchner C, Maier S, Innerhofer P, Kolbitsch C, Streif W, Mittermayr M, Praxmarer M, Fries D.

Anesth Analg. 2009 Jun;108(6):1747-54. doi: 10.1213/ane.0b013e3181a198ac.

PMID:
19448196
6.

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control.

Watala C, Golanski J, Pluta J, Boncler M, Rozalski M, Luzak B, Kropiwnicka A, Drzewoski J.

Thromb Res. 2004;113(2):101-13.

PMID:
15115665
7.

Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?

von Lewinski F, Riggert J, Paulus W.

J Stroke Cerebrovasc Dis. 2009 Mar-Apr;18(2):111-5. doi: 10.1016/j.jstrokecerebrovasdis.2008.09.010.

PMID:
19251186
9.
10.

Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils.

González-Correa JA, Muñoz-Marín J, López-Villodres JA, Navas MD, Guerrero A, Torres JA, De La Cruz JP.

Pharmacol Res. 2007 Aug;56(2):168-74. Epub 2007 Jun 6.

PMID:
17644353
11.

The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.

Serebruany VL, Kogushi M, Dastros-Pitei D, Flather M, Bhatt DL.

Thromb Haemost. 2009 Jul;102(1):111-9. doi: 10.1160/TH08-12-0805.

PMID:
19572075
12.
13.

Effect of low doses of ethanol on platelet function in long-life abstainers and moderate-wine drinkers.

Miceli M, Alberti L, Bennardini F, Di Simplicio P, Seghieri G, Rao GH, Franconi F.

Life Sci. 2003 Aug 8;73(12):1557-66.

PMID:
12865095
14.

Inhibition of human platelet function by parsalmide.

Fantasia R, Colombi M, Della Volpe A, Pogliani EM.

Arzneimittelforschung. 1982;32(10):1312-4.

PMID:
6897511
15.

Platelet function in whole-blood donors is impaired: the effects of painkillers.

Curvers J, Dielis AW, Heeremans J, van Wersch JW.

Transfusion. 2007 Jan;47(1):67-73.

PMID:
17207232
16.

Effects of acetylsalicylic acid on human platelet function in vivo at salicylate steady state.

Simrock R, Missalla A, Schwidtal P, Lischke V, Breddin HK.

Thromb Haemost. 1984 Apr 30;51(2):269-71.

PMID:
6740559
17.

Influence of combinations of acetylsalicylic acid, acetaminophen, and diclofenac on platelet aggregation.

Galliard-Grigioni KS, Fehr M, Reinhart WH.

Eur J Pharmacol. 2008 Oct 24;595(1-3):65-8. doi: 10.1016/j.ejphar.2008.07.036. Epub 2008 Jul 30.

PMID:
18700139
18.

Inhibition of platelet-vessel wall interactions by thromboxane receptor antagonism in a human in vitro system: potentiation of antiplatelet effects of aspirin.

Escolar G, Albors M, Garrido M, Bioque G, Díaz Ricart M, Carretero M, Ordinas A.

Eur J Clin Invest. 1998 Jul;28(7):562-8.

PMID:
9726037
19.

Increased sensitivity to ADP-aggregation in aspirin treated patients with recurrent ischemic stroke?

Mattiasson I, Lethagen S, Hillarp A.

Int Angiol. 2003 Sep;22(3):239-42.

PMID:
14612850
20.

Can we use adenosine diphosphate (ADP) to study "aspirin resistance"? The Janus faces of ADP-triggered platelet aggregation.

Dobaczewski M, Golański J, Kowalski T, Nocuń M, Rózalski M, Kostka B, Ulicna O, Mussur M, Markuszewski L, Watała C.

Pharmacol Rep. 2008 May-Jun;60(3):361-8.

Supplemental Content

Support Center